Table 4.
(%) | Normocholesterolemic | Hypercholesterolemic | p Value | ||||||
---|---|---|---|---|---|---|---|---|---|
OPO n = 65 |
HOSO n = 34 |
SO n = 31 |
OPO n = 67 |
HOSO n = 30 |
SO n = 37 |
Oil | N/H | Oil × N/H | |
Weight | −0.3 ± 0.1 | 0.2 ± 0.2 | 0.0 ± 0.2 | 0.0 ± 0.1 | 0.1 ± 0.2 | 0.1 ± 0.2 | 0.392 | 0.508 | 0.715 |
BMI | −0.4 ± 0.2 | 0.3 ± 0.5 | 0.3 ± 0.5 | 0.1 ± 0.1 | 0.0 ± 0.3 | 0.4 ± 0.3 | 0.251 | 0.700 | 0.421 |
Body fat | −0.3 ± 1.5 | 1.8 ± 2.3 | −1.0 ± 1.1 | 2.5 ± 1.5 | 3.3 ± 3.0 | 3.8 ± 2.2 | 0.476 | 0.064 | 0.726 |
Visceral fat | −1.5 ± 2.4 | −3.9 ± 2.6 | 2.2 ± 4.0 | −1.1 ± 1.3 | −2.9 ± 2.4 | 6.6 ± 6.1 | 0.146 | 0.706 | 0.953 |
Waist | −0.5 ± 0.5 | 1.1 ± 0.9 | −0.8 ± 0.9 | −0.8 ± 0.4 | 1.6 ± 1.3 | −0.6 ± 0.8 | 0.026 | 0.745 | 0.620 |
Hip | 0.6 ± 0.9 | 1.1 ± 0.4 | 0.4 ± 0.4 | 0.3 ± 0.2 | 0.0 ± 0.2 | 1.2 ± 0.9 | 0.619 | 0.615 | 0.335 |
Values represent mean ± standard error of mean. The rate of change was calculated from [(post-treatment value − pre-treatment value)/pre-treatment value] and expressed as percentage. A linear mixed model was used for data analysis. p-value in the first column represents the treatment effect (OPO, HOSO or SO), in the second column the group effect [normocholesterolemic (N) and hypercholesterolemic (H)], and in the last column the interaction of treatment and group. Significance level was set at p < 0.05. BMI: body mass index.